A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 131
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : FACIT-F
Long Form : Functional Assessment of Chronic Illness Therapy-Fatigue
No. Year Title Co-occurring Abbreviation
2020 A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures. NCORP, URMC
2020 Biologic disease-modifying anti-rheumatic drugs and patient-reported outcomes in axial SpA: a systematic review and a call for action. ASQoL, axSpA, BASDAI, BASFI, bDMARDs, EQ-5D, IL17Ai, MCID, nr-axSpA, PBO, PROs, r-axSpA, RCT, SF36-MCS, SF36-PCS, SLR, TNFi
2020 Bristol rheumatoid arthritis fatigue scale is valid in patients with psoriatic arthritis and is associated with overall severe disease and higher comorbidities. CCI, PsA
2020 Conversion of FACIT-F to PROMIS Fatigue Scores in Two Phase 3 Baricitinib Rheumatoid Arthritis Trials. IRT, PROMIS, RA
2020 Depression, disability and sleep disturbance are the main explanatory factors of fatigue in rheumatoid arthritis: a path analysis model. RA
2020 Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study. BASDAI, BASFI, BASRI-s, CASPAR, DAS 28-ESR, HADS, HAQ, HAQ-s, MASES, PASI, PsA, PsAQoL, SF-36, TLAR
2020 Eurythmy therapy versus slow movement fitness in the treatment of fatigue in metastatic breast cancer patients: study protocol for a randomized controlled trial. CRF, ERYT
2020 Fatigue and associated factors in a multi-ethnic cohort of rheumatoid arthritis patients. csDMARDs, DAS28-ESR, HRQoL, RA
2020 Health-Related Quality of Life and Burden of Fatigue in Chinese Patients with Immune Thrombocytopenia: A Cross-Sectional Study. CI, HRQoL, ITP
10  2020 Health-related quality of life and fatigue in patients with chronic hepatitis C with therapy with direct-acting antivirals agents interferon-free. ANOVA, CLDQ, DAA, HRQoL, IFN, PROs, PROs, PROs, RBV, SF-36, SVR
11  2020 Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus. BILD, HRQoL, LIT, SF-36, SLAQ, SLE
12  2020 Interventions for fatigue in inflammatory bowel disease. AEs, CBT, IBD, IBD-F, MD
13  2020 Psychometric Properties of the Arabic Version of the Functional Assessment of Chronic Illnesses Therapy-Fatigue in Arabic Cancer Patients. FACIT, FACT-G
14  2020 The efficacy of placebo for the treatment of cancer-related fatigue: a systematic review and meta-analysis. BFI, CRF
15  2020 The impact of fatigue on patients with psoriatic arthritis: amulti-center study of the TLAR-network. BASDAI, cDAPSA, DAPSA, DAS28, FiRST, MDA, PsA, TLAR, VLDA
18  2019 Cytokine balance is restored as patient-reported outcomes improve in patients recovering from chronic hepatitis C. BDI-II, CHC, CLDQ-HCV, FSS, PROs, SF-36, SVR
19  2019 Disease activity and sleep quality in rheumatoid arthritis: a deeper look into the relationship. DAS28, HRQoL, PSQI, RA
20  2019 Effect of balneotherapy on pain and fatigue in elderly with knee osteoarthritis receiving physical therapy: a randomized trial. BT, EPWORTH, KOA, PT, WOMAC
21  2019 Evaluation of fatigue in inflammatory bowel disease - a useful tool in daily practice. CD, IBD
22  2019 Fatigue and Functional Ability in Patients Undergoing Upfront Surgical Treatment for Solid Malignancies. MFI-20
23  2019 Fatigue predicts impaired social adjustment in survivors of allogeneic hematopoietic cell transplantation (HCT). DE, ER, HCT, PAIS, SE, SEX, VE
24  2019 Investigating the relationships between quality of life, fatigue and leisure time physical activity in prostate cancer patients. FACT-P, GLTEQ, PCa
25  2019 Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia. EQ-5D-5L, FAACT, HRQoL, MAE, RMSE, TOI
26  2019 Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial. RA
27  2019 The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis. EQ5D3L, HADS, HRQoL, MES, PROs, SIBDQ, UC, WPAI
28  2019 Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib. AEs, CFB, csDMARD, HAQ-DI, LDA, RA, RF, SF-36
29  2019 Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder. CI, NMOSD, VAS
30  2019 Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT. HAQ-DI, LSM, MCIDs, NNT, PROs, PtGA, SF-36
31  2018 Anxiety and Extraversion in Lupus-Related Atherosclerosis. CVD, IMT, SLE, STAI
32  2018 Effects of Exergaming in Cancer Related Fatigue in the Quality of Life and Electromyography of the Middle Deltoid of People with Cancer in Treatment: A Controlled Trial ---
33  2018 Evaluation of health-related quality of life in hemolytic uraemic syndrome patients treated with eculizumab: a systematic evaluation on basis of EMPRO. aHUS, ECU, EMPRO, HIT-6, HRQoL, HUS, PROs, QOL, VAS
34  2018 Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial. CRP, EE, HAQ-DI, MCIDs, PROs, PsA, SF-36, TNFi
35  2018 Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. CLL/SLL
36  2018 Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis. HAQ-DI, LSM, MCID, MCS, PCS, PROs, PtGA, RA, RAID, VASs
37  2018 Potential Role of Bupropion Sustained Release for Cancer-Related Fatigue: a Double-Blind, Placebo-Controlled Study ANCOVA, CRF, SR
38  2018 Prevalence and Correlation of Depressive Symptoms with Functional Scores, Therapy and Disease Activity among Croatian Patients with Rheumatoid Arthritis: A Preliminary Study. BDI-II, DAS28, HAQ, HRQL, RA, VAS
39  2018 Shenmai injection for the treatment of cancer-related fatigue in advanced non-small cell lung cancer patients undergoing chemotherapy: study protocol for a randomized controlled trial. CRF, NSCLC, RCT, SMI, TCM
40  2018 The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus. ESR, HRQoL, SLE, SLEDAI, SLEQOL-C
41  2018 Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial. csDMARDs, HAQ-DI, PGA, PtGA, RA, SF-36, WLQ
42  2018 Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C. CLDQ, DCV, HCV, PROs, RBV, SF-36, SMV, SOF
43  2017 A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population. FACT-Br, HRQoL, NCCN-DT
44  2017 A Double-Blind, Randomized, Placebo-Controlled Trial of Panax Ginseng for Cancer-Related Fatigue in Patients With Advanced Cancer. CRF, ESAS, PG, QOL
45  2017 Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies. LTE
46  2017 Evaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis. BASDAI, CDAI, FACIT-FS, HAD, HAD A, HAD D, HAQ, PASI, PDI
47  2017 Fatigue and sleep quality in rheumatoid arthritis patients during hospital admission. PSQI, RA
48  2017 Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study. EQ-5D, HAQ-DI, MJS, MTX, PROs, PtGA, WPAI-RA
49  2017 Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis. HAQ-DI, MJS, PROs, PtGA, RA, VAS
50  2017 Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON). bDMARDs, HAQ-DI, MJS, PROs, PtGA, RA-BEACON, TNFis
51  2017 Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients. HADS, IBD, PROs, SF-36, SIBDQ, WPAI
52  2017 Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment. ANCOVA, DMARDs, EQ-5D, HAQ-DI, MJS, MTX, PROs, PtGA, RA, SF-36, WPAI-RA
53  2017 Predictors of health-related quality of life in Korean prostate cancer patients receiving androgen deprivation therapy. ADT, FACT-P, HADS, HRQoL
54  2017 Psychometric properties of the Chinese version of Arthritis Self-Efficacy Scale-8 (ASES-8) in a rheumatoid arthritis population. ASES-8, HADS, ICC, SF-36
55  2017 Subjective measures of work-related fatigue in automobile factory employees. MFI, PSQI, WCQ
56  2017 The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients. SSc
57  2017 Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled Trial. DMARDs, HAQ DI, MOS-Sleep, PROs, PtGA, RA, SF-36
58  2016 A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy. BFI, CFS, FACT-G, QOL, RT
59  2016 Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens. CLDQ-HCV, HCV, PROs, RBV, SF-36, SOF, WPAI
60  2016 Art therapy using famous painting appreciation maintains fatigue levels during radiotherapy in cancer patients. BFI, QOL
61  2016 Biologic interventions for fatigue in rheumatoid arthritis. anti-TNF, CENTRAL, CI, DMARDs, NRS, RA, SF-36 VT, VAS
62  2016 Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1). AS, ASQoL, BASDAI, BASDAI 50, BASFI, EQ-5D, MCS, PCS, s.c, SF-36, WPAI-GH
63  2016 Efficacy of rehabilitation with Tai Ji Quan in an Italian cohort of patients with Fibromyalgia Syndrome. FIQ, FMS, HADS, HAQ, MBT, PSQI, QOL, SF36, TJQ, TP, WPI
64  2016 Fatigue in intensive care survivors one year after discharge. ICU, LOS, VT
65  2016 Fatigue in Patients With Advanced Terminal Cancer Correlates With Inflammation, Poor Quality of Life and Sleep, and Anxiety/Depression. CFQ, EORTC, FACT, HADS, mGPS, PSQI-BR
66  2016 Functional assessment of chronic illness therapy-the fatigue scale exhibits stronger associations with clinical parameters in chronic dialysis patients compared to other fatigue-assessing instruments. BFI, ESRD, FQ, FSI, FSS, LFS, SF36-V
67  2016 Impact of fatigue in patients with chronic obstructive pulmonary disease: results from an exploratory study. CCQ, COPD
68  2016 Mental and Emotional Impairment in Patients With Hepatitis C is Related to Lower Work Productivity. CLDQ-HCV, EM, HCV, MEH, SF-36, WP, WPAI
69  2016 Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial. CLDQ-HCV, HCV, PROs, WPAI
70  2016 Physical activity and exercise capacity in patients with moderate COPD exacerbations. QMVC
71  2016 Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial. ISAPA, SF-36
72  2016 Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial. HAQ-DI, MCID, PROs, PtGA, RA, RCT, SF-36
73  2016 Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial. HAQ-DI, MTX, PCS, PROs, PtGA, SF-36
74  2016 [Effect of Cancer Symptoms and Fatigue on Chemotherapy-related Cognitive Impairment and Depression in People with Gastrointestinal Cancer]. CRCI, ECog, HADS
75  2015 Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia. CACS, FAACT, NSCLC, QOL, SEA, SEF
76  2015 Cancer related fatigue: A ubiquitous problem yet so under reported, under recognized and under treated. CRF, ECOG, OPD
77  2015 Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis? CDC, HRQoL, MCS, PCS, RA, SF-36, VAS-Pain
78  2015 Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis. CAPRA, DMARD, DR, FACT-G, RA, SF-36
79  2015 Determination of the minimal clinically important difference for seven measures of fatigue in Swedish patients with systemic lupus erythematosus. CFS, FSS, MAF, MCID, MFI, NRS, SLE, VT
80  2015 Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs. DMARD-IR, HAQ-DI, IVRS, MOS, PROs, PtGA, SF-36
81  2015 Endoscopist Fatigue May Contribute to a Decline in the Effectiveness of Screening Colonoscopy. ADR
82  2015 High-Dose Asian Ginseng (Panax Ginseng) for Cancer-Related Fatigue: A Preliminary Report. CRF, ESAS, GSE, HADS, PG
83  2015 Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir. CLDQ-HCV, HRQL, SF-36, WPAI
84  2015 Tofacitinib with methotrexate in third-line treatment of patients with active rheumatoid arthritis: patient-reported outcomes from a phase III trial. DI, HAQ, MOS, PROs, PtGA, RA, TNFi
85  2015 Validation and psychometric properties of the Eular Sjogren's Syndrome Patient Reported Index (ESSPRI) into Brazilian Portuguese. ESSPRI, ICC, PGA, SS, SSI
86  2014 Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients. FACT-G, HGG, QOL
87  2014 Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: the VALENCE study. CLDQ-HCV, IFN, PROs, SF-36, SOF, WPAI
88  2014 Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens. CLDQ-HCV, PROs, RBV, SF-36, SOF, SVR12, WPAI-SHP
89  2014 The comparability of English, French and Dutch scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): an assessment of differential item functioning in patients with systemic sclerosis. DIF, MIMIC, SD, SSc
90  2014 Therapeutic horseback riding in breast cancer survivors: a pilot study. EAT
91  2013 Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial. MSLT
92  2013 Fatigue in Parkinson's disease: measurement properties of a generic and a condition-specific rating scale. ---
93  2013 In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 muU/mL after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin. DTC, Tg, THW
94  2013 Measurement of fatigue in cancer, stroke, and HIV using the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) scale. PROMIS
95  2013 Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. CRF, CTI, ESAS, MP, NTI, PL
96  2013 Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. ESAS, MDAS, Nu-DESC, UMRS
97  2013 Patient-reported Health-related Quality of Life with apremilast for psoriatic arthritis: a phase II, randomized, controlled study. HAQ-DI, HRQoL, MCID, PRO, PsA, RCT, SF-36, VAS
98  2013 Prevalence and correlates of fatigue in chronic kidney disease and end-stage renal disease: are sleep disorders a key to understanding fatigue? CKD, ESRD
99  2013 Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. CRF, ESAS
100  2012 Acupuncture for symptoms of Gaucher disease. GD, MCS, MOS, PCS, PWB, SF